Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A

被引:75
作者
Baroja, ML
Vijayakrishnan, L
Bettelli, E
Darlington, PJ
Chau, TA
Ling, V
Collins, M
Carreno, BM
Madrenas, J
Kuchroo, VK
机构
[1] Univ Western Ontario, Transplantat & Immunobiol Grp, John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada
[3] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada
[4] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA 02115 USA
[6] Genet Inst Inc, Cambridge, MA 02140 USA
关键词
D O I
10.4049/jimmunol.168.10.5070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The catalytic subunit of the serine/threonine phosphatase 2A (MA) can interact with the cytoplasmic tail of CTLA-4. However, the molecular basis and the biological significance of this interaction are unknown. In this study, we report that the regulatory subunit of PP2A (PP2AA) also interacts with the cytoplasmic tail of CTLA-4. Interestingly, TCR ligation induces tyrosine phosphorylation of PP2AA and its dissociation from CTLA-4 when coligated. The association between PP2AA and CTLA-4 involves a conserved three-lysine motif in the juxtamembrane portion of the cytoplasmic tail of CTLA-4. Mutations of these lysine residues prevent the binding of PP2AA and enhance the inhibition of IL-2 gene transcription by CTLA-4, indicating that PP2A represses CTLA-4 function. Our data imply that the lysine-rich motif in CTLA-4 may be used to identify small molecules that block its binding to PP2A and act as agonists for CTLA-4 function.
引用
收藏
页码:5070 / 5078
页数:9
相关论文
共 38 条
[1]   CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].
Abrams, JR ;
Lebwohl, MG ;
Guzzo, CA ;
Jegasothy, BV ;
Goldfarb, MT ;
Goffe, BS ;
Menter, A ;
Lowe, NJ ;
Krueger, G ;
Brown, MJ ;
Weiner, RS ;
Birkhofer, MJ ;
Warner, GL ;
Berry, KK ;
Linsley, PS ;
Krueger, JG ;
Ochs, HD ;
Kelley, SL ;
Kang, SW .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252
[2]   The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation [J].
Baroja, ML ;
Luxenberg, D ;
Chau, T ;
Ling, V ;
Strathdee, CA ;
Carreno, BM ;
Madrenas, J .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :49-55
[3]   Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH4-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70 [J].
Calvo, CR ;
Amsen, D ;
Kruisbeek, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1645-1653
[4]   IDENTIFICATION OF REGIONS IN POLYOMAVIRUS MIDDLE-T AND SMALL-T ANTIGENS IMPORTANT FOR ASSOCIATION WITH PROTEIN PHOSPHATASE-2A [J].
CAMPBELL, KS ;
AUGER, KR ;
HEMMINGS, BA ;
ROBERTS, TM ;
PALLAS, DC .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3721-3728
[5]   CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression [J].
Carreno, BM ;
Bennett, F ;
Chau, TA ;
Ling, V ;
Luxenberg, D ;
Jussif, J ;
Baroja, ML ;
Madrenas, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1352-1356
[6]   Costimulatory regulation of T cell function [J].
Chambers, CA ;
Allison, JP .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :203-210
[7]   Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor [J].
Chau, LA ;
Bluestone, JA ;
Madrenas, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1699-1709
[8]   REGULATION OF PROTEIN SERINE-THREONINE PHOSPHATASE TYPE-2A BY TYROSINE PHOSPHORYLATION [J].
CHEN, J ;
MARTIN, BL ;
BRAUTIGAN, DL .
SCIENCE, 1992, 257 (5074) :1261-1264
[9]   The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A [J].
Chuang, E ;
Fisher, TS ;
Morgan, RW ;
Robbins, MD ;
Duerr, JM ;
Vander Heiden, MG ;
Gardner, JP ;
Hambor, JE ;
Neveu, MJ ;
Thompson, CB .
IMMUNITY, 2000, 13 (03) :313-322
[10]  
Chuang E, 1999, J IMMUNOL, V162, P1270